Parameter
| Biomarker | has-miR-20a-5p/SNHG16, has-miR-181a-5p/SNHG6 | Full name | has-microR-20a-5p/small nucleolar RNA host gene 6, has-microR-181a-5p/small nucleolar RNA host gene 6 | Molecular Type | Nucleic acid (ceRNA network) |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | Core Functional Dimensions | Prognosis | ||
| Disease | Non-Hodgkin Lymphoma (NHL) | Disease Subtypes | / | ||
| Organ | Lymphoid tissue | Test Sample / Technology Platform | Plasma (RT-qPCR, bioinformatics) | ||
| Pathobiological Mechanisms | Association of disease invasiveness with score, independent prognostic factor | ||||
| Clinical Availability Status | Validation phase of the study: 113 patients were validated, requiring multicenter and storage stability assessment. | ||||
| Notes and Dynamics | Establishing a prognostic scoring system to explore the value of dynamic treatment monitoring. | ||||